Versigent Q2 EPS $1.92 Beats $1.35 Estimate, Sales $2.444B Beat $2.313B Estimate
Versigent (NYSE:VGNT) reported quarterly earnings of $1.92 per share which beat the analyst consensus estimate of $1.35 by 42.22 percent. The company reported quarterly sales of $2.444 billion which beat the analyst
